Douglas P. Zipes MD
Distinguished Professor, Professor Emeritus of Medicine, Pharmacology and Toxicology, Emeritus Director of the Division of Cardiology and Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IndianaDr. Douglas P. Zipes is Distinguished Professor, Professor Emeritus of Medicine, Pharmacology and Toxicology, and Emeritus Director of the Division of Cardiology and Krannert Institute of Cardiology at Indiana University School of Medicine. He received his medical degree from Harvard Medical School and trained at Duke University Medical Center in medicine and cardiology. He joined Indiana University in 1970, became Distinguished Professor in 1994, and then Director of Cardiology (1995–2004).
Having published almost 1000 medical articles and 16 textbooks with multiple editions, Dr. Zipes is the recipient of numerous awards from the American Heart Association, the Heart Rhythm Society, the American College of Cardiology, and the European Society of Cardiology, among other professional societies and institutions.
He is past president of the American College of Cardiology and the Heart Rhythm Society, and past chair of the American Board of Internal Medicine. He is a fellow of the Heart Rhythm Society, American Heart Association, European Society of Cardiology. He is Master of the American College of Physicians and American College of Cardiology, and he is a member of the American Society for Clinical Investigation and the Association of American Physicians. In addition, Dr. Zipes retains honorary membership in the Cardiac Society of Australia and New Zealand, Argentine Society of Cardiology, Hungarian Society of Cardiology, and Israel Heart Society.
Recent Contributions to PracticeUpdate:
- External Defibrillators Delivered by Drones to Patients With Suspected Out-of-Hospital Cardiac Arrest
- ESC 2021: Recommendations From Dr. Doug Zipes
- Risk Thresholds for Total and Beverage-Specific Alcohol Consumption and Incident Atrial Fibrillation
- Fully Implantable and Bioresorbable Cardiac Pacemakers Without Leads or Batteries
- PPIs Block hERG-Potassium Channels and Increase the Risk of QTc Prolongation
- Left Atrial Appendage Occlusion During Cardiac Surgery to Prevent Stroke
- Finerenone Reduces Onset of Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes
- ACC 2021: Abstract Recommendations From Dr. Doug Zipes
- Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 During the Early Phase of the Pandemic
- Early Recurrence Is Reliable Predictor of Late Recurrence After Radiofrequency Catheter Ablation of Atrial Fibrillation